Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37697139)

  • 1. Comprehensive profiling of enhancer RNA in stage II/III colorectal cancer defines two prognostic subtypes with implications for immunotherapy.
    Bu X; Liu S; Zhang Z; Wu J; Pan S; Hu Y
    Clin Transl Oncol; 2024 Apr; 26(4):891-904. PubMed ID: 37697139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy.
    Bu X; Liu S; Wen D; Kan A; Xu Y; Lin X; Shi M
    Mol Ther Oncolytics; 2022 Sep; 26():226-244. PubMed ID: 35919459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
    Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
    Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
    [No Abstract]   [Full Text] [Related]  

  • 4. Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers.
    Cai YM; Lu ZQ; Li B; Huang JY; Zhang M; Chen C; Fan LY; Ma QY; He CY; Chen SN; Jiang Y; Li YM; Ning CB; Zhang FW; Wang WZ; Liu YZ; Zhang H; Jin M; Wang XY; Han JX; Xiong Z; Cai M; Huang CQ; Yang XJ; Zhu X; Zhu Y; Miao XP; Zhang SK; Wei YC; Tian JB
    Mil Med Res; 2024 Jun; 11(1):36. PubMed ID: 38863031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
    Lin A; Zhang J; Luo P
    Front Immunol; 2020; 11():2039. PubMed ID: 32903444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
    Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
    Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
    Picard E; Verschoor CP; Ma GW; Pawelec G
    Front Immunol; 2020; 11():369. PubMed ID: 32210966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtyping of microsatellite instability-high colorectal cancer.
    Hu W; Yang Y; Qi L; Chen J; Ge W; Zheng S
    Cell Commun Signal; 2019 Jul; 17(1):79. PubMed ID: 31331345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The landscape of enhancer RNA identify prognosis-related molecular subtypes in gastric cancer.
    Yan A; Chen Y; Bian R; Wang C; Que H; Shen Y; Lu X
    Cancer Med; 2023 Jan; 12(2):2046-2057. PubMed ID: 35801342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
    Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
    Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers.
    Xiao J; Liu Y; Yi J; Liu X
    Front Mol Biosci; 2021; 8():646786. PubMed ID: 33996902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in immunotyping of colorectal cancer.
    Wu Y; Zhuang J; Qu Z; Yang X; Han S
    Front Immunol; 2023; 14():1259461. PubMed ID: 37876934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer.
    Sahu D; Lin CC; Goel A
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eRNAs Identify Immune Microenvironment Patterns and Provide a Novel Prognostic Tool in Acute Myeloid Leukemia.
    Jiang Z; Long J; Deng K; Zheng Y; Chen M
    Front Mol Biosci; 2022; 9():877117. PubMed ID: 35586193
    [No Abstract]   [Full Text] [Related]  

  • 19. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.